Publications by the researcher in collaboration with Manuel Ángel Gómez Marcos (17)

2012

  1. Osteoprotegerin is associated with cardiovascular risk in hypertension and/or diabetes

    European Journal of Clinical Investigation, Vol. 42, Núm. 5, pp. 548-556